Switch to:
Also traded in: Brazil, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.71
NYSE:AET's Cash-to-Debt is ranked lower than
68% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.38 vs. NYSE:AET: 0.71 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:AET' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.32  Med: 9.59 Max: 59.86
Current: 0.71
0.32
59.86
Equity-to-Asset 0.27
NYSE:AET's Equity-to-Asset is ranked lower than
68% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.34 vs. NYSE:AET: 0.27 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:AET' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.06  Med: 0.2 Max: 0.3
Current: 0.27
0.06
0.3
Debt-to-Equity 0.60
NYSE:AET's Debt-to-Equity is ranked higher than
56% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.66 vs. NYSE:AET: 0.60 )
Ranked among companies with meaningful Debt-to-Equity only.
NYSE:AET' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.09  Med: 0.22 Max: 1.24
Current: 0.6
0.09
1.24
Interest Coverage 5.58
NYSE:AET's Interest Coverage is ranked lower than
87% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.62 vs. NYSE:AET: 5.58 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:AET' s Interest Coverage Range Over the Past 10 Years
Min: 5.58  Med: 12.26 Max: 15.48
Current: 5.58
5.58
15.48
Piotroski F-Score: 5
Altman Z-Score: 2.24
Beneish M-Score: -2.34
WACC vs ROIC
4.76%
11.92%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 5.72
NYSE:AET's Operating Margin % is ranked lower than
60% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.19 vs. NYSE:AET: 5.72 )
Ranked among companies with meaningful Operating Margin % only.
NYSE:AET' s Operating Margin % Range Over the Past 10 Years
Min: 5.47  Med: 7.76 Max: 10.89
Current: 5.72
5.47
10.89
Net Margin % 2.52
NYSE:AET's Net Margin % is ranked lower than
68% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.19 vs. NYSE:AET: 2.52 )
Ranked among companies with meaningful Net Margin % only.
NYSE:AET' s Net Margin % Range Over the Past 10 Years
Min: 2.52  Med: 4.26 Max: 6.63
Current: 2.52
2.52
6.63
ROE % 9.37
NYSE:AET's ROE % is ranked lower than
83% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.42 vs. NYSE:AET: 9.37 )
Ranked among companies with meaningful ROE % only.
NYSE:AET' s ROE % Range Over the Past 10 Years
Min: 9.37  Med: 15.65 Max: 19.85
Current: 9.37
9.37
19.85
ROA % 2.41
NYSE:AET's ROA % is ranked lower than
80% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.26 vs. NYSE:AET: 2.41 )
Ranked among companies with meaningful ROA % only.
NYSE:AET' s ROA % Range Over the Past 10 Years
Min: 2.41  Med: 4.05 Max: 5.2
Current: 2.41
2.41
5.2
ROC (Joel Greenblatt) % 541.26
NYSE:AET's ROC (Joel Greenblatt) % is ranked higher than
86% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 89.82 vs. NYSE:AET: 541.26 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NYSE:AET' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 421.13  Med: 565.4 Max: 919.39
Current: 541.26
421.13
919.39
3-Year Revenue Growth Rate 10.60
NYSE:AET's 3-Year Revenue Growth Rate is ranked higher than
57% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.60 vs. NYSE:AET: 10.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NYSE:AET' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -15.7  Med: 5.3 Max: 22
Current: 10.6
-15.7
22
3-Year EBITDA Growth Rate 11.60
NYSE:AET's 3-Year EBITDA Growth Rate is ranked lower than
53% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.80 vs. NYSE:AET: 11.60 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NYSE:AET' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 2.6 Max: 76.7
Current: 11.6
0
76.7
3-Year EPS without NRI Growth Rate 6.30
NYSE:AET's 3-Year EPS without NRI Growth Rate is ranked lower than
53% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.40 vs. NYSE:AET: 6.30 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NYSE:AET' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -13  Med: 6.4 Max: 63.9
Current: 6.3
-13
63.9
GuruFocus has detected 6 Warning Signs with Aetna Inc $NYSE:AET.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:AET's 30-Y Financials

Financials (Next Earnings Date: 2017-10-31)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

AET Guru Trades in Q3 2016

Chris Davis 1,504,313 sh (New)
Louis Moore Bacon 2,471 sh (New)
Paul Tudor Jones 9,710 sh (+341.36%)
Jim Simons 1,105,682 sh (+250.13%)
Joel Greenblatt 25,149 sh (+60.98%)
Diamond Hill Capital 1,078,124 sh (+35.59%)
Richard Pzena 155,248 sh (+0.09%)
Jeff Auxier 5,316 sh (+0.02%)
Vanguard Health Care Fund 8,174,089 sh (unchged)
Larry Robbins 5,179,716 sh (unchged)
Lee Ainslie 5,330 sh (unchged)
George Soros Sold Out
Andreas Halvorsen Sold Out
First Pacific Advisors Sold Out
John Buckingham 89,444 sh (-2.59%)
Pioneer Investments 1,232,493 sh (-3.62%)
David Dreman 9,163 sh (-7.01%)
Jeremy Grantham 201,681 sh (-76.29%)
» More
Q4 2016

AET Guru Trades in Q4 2016

George Soros 31,000 sh (New)
David Swensen 2,240 sh (New)
Steven Cohen 125,469 sh (New)
Ray Dalio 189,000 sh (New)
John Burbank 69,424 sh (New)
Jana Partners 892,719 sh (New)
Lee Ainslie 2,229,816 sh (+41735.20%)
Chris Davis 3,937,198 sh (+161.73%)
Jim Simons 2,842,782 sh (+157.11%)
Joel Greenblatt 37,850 sh (+50.50%)
Diamond Hill Capital 1,547,498 sh (+43.54%)
Larry Robbins 5,194,064 sh (+0.28%)
Richard Pzena 155,248 sh (unchged)
Jeff Auxier 5,316 sh (unchged)
Jana Partners 2,100,000 sh (unchged)
John Buckingham 87,655 sh (-2.00%)
Paul Tudor Jones 9,411 sh (-3.08%)
Vanguard Health Care Fund 6,754,289 sh (-17.37%)
Jeremy Grantham 71,644 sh (-64.48%)
Pioneer Investments 90,499 sh (-92.66%)
David Dreman 343 sh (-96.26%)
» More
Q1 2017

AET Guru Trades in Q1 2017

Eaton Vance Worldwide Health Sciences Fund 191,137 sh (New)
Louis Moore Bacon 25,000 sh (+911.74%)
Steven Cohen 228,300 sh (+81.96%)
Paul Tudor Jones 16,335 sh (+73.57%)
Jana Partners 1,450,016 sh (+62.43%)
Joel Greenblatt 44,978 sh (+18.83%)
Jim Simons 3,111,482 sh (+9.45%)
Diamond Hill Capital 1,656,372 sh (+7.04%)
Chris Davis 4,163,857 sh (+5.76%)
David Dreman Sold Out
George Soros Sold Out
David Swensen Sold Out
John Burbank Sold Out
Jeff Auxier 5,307 sh (-0.17%)
Richard Pzena 154,946 sh (-0.19%)
Pioneer Investments 90,146 sh (-0.39%)
Larry Robbins 5,029,073 sh (-3.18%)
John Buckingham 82,287 sh (-6.12%)
Vanguard Health Care Fund 5,230,989 sh (-22.55%)
Ray Dalio 85,970 sh (-54.51%)
Lee Ainslie 987,480 sh (-55.71%)
Jeremy Grantham 24,877 sh (-65.28%)
» More
Q2 2017

AET Guru Trades in Q2 2017

Dodge & Cox 1,400 sh (New)
David Dreman 7,320 sh (New)
Richard Pzena 154,946 sh (unchged)
Jeff Auxier 5,307 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 191,137 sh (unchged)
Ray Dalio Sold Out
Jana Partners Sold Out
Louis Moore Bacon Sold Out
Paul Tudor Jones Sold Out
John Buckingham 81,952 sh (-0.41%)
Diamond Hill Capital 1,630,235 sh (-1.58%)
Vanguard Health Care Fund 5,101,289 sh (-2.48%)
Chris Davis 3,980,111 sh (-4.41%)
Jeremy Grantham 22,277 sh (-10.45%)
Pioneer Investments 78,035 sh (-13.43%)
Larry Robbins 3,310,469 sh (-34.17%)
Joel Greenblatt 28,625 sh (-36.36%)
Steven Cohen 128,600 sh (-43.67%)
Jim Simons 1,290,092 sh (-58.54%)
Lee Ainslie 11,470 sh (-98.84%)
» More
» Details

Insider Trades

Latest Guru Trades with NYSE:AET

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Vanguard Health Care Fund 2017-06-30 Reduce -2.48%0.04%$127.28 - $152.98 $ 153.579%5,101,289
Chris Davis 2017-06-30 Reduce -4.41%0.1%$127.28 - $152.98 $ 153.579%3,980,111
Joel Greenblatt 2017-06-30 Reduce -36.36%0.03%$127.28 - $152.98 $ 153.579%28,625
David Dreman 2017-06-30 New Buy0.61%$127.28 - $152.98 $ 153.579%7,320
Dodge & Cox 2017-06-30 New Buy$127.28 - $152.98 $ 153.579%1,400
Vanguard Health Care Fund 2017-03-31 Reduce -22.55%0.45%$116.71 - $134.11 $ 153.5722%5,230,989
Chris Davis 2017-03-31 Add 5.76%0.12%$116.71 - $134.11 $ 153.5722%4,163,857
Richard Pzena 2017-03-31 Reduce -0.19%$116.71 - $134.11 $ 153.5722%154,946
Joel Greenblatt 2017-03-31 Add 18.83%0.01%$116.71 - $134.11 $ 153.5722%44,978
David Dreman 2017-03-31 Sold Out 0.02%$116.71 - $134.11 $ 153.5722%0
David Swensen 2017-03-31 Sold Out 0.05%$116.71 - $134.11 $ 153.5722%0
George Soros 2017-03-31 Sold Out 0.13%$116.71 - $134.11 $ 153.5722%0
Vanguard Health Care Fund 2016-12-31 Reduce -17.37%0.35%$105.2 - $134.9 $ 153.5728%6,754,289
Chris Davis 2016-12-31 Add 161.73%1.32%$105.2 - $134.9 $ 153.5728%3,937,198
Joel Greenblatt 2016-12-31 Add 50.50%0.02%$105.2 - $134.9 $ 153.5728%37,850
George Soros 2016-12-31 New Buy0.13%$105.2 - $134.9 $ 153.5728%31,000
David Swensen 2016-12-31 New Buy0.05%$105.2 - $134.9 $ 153.5728%2,240
David Dreman 2016-12-31 Reduce -96.26%0.62%$105.2 - $134.9 $ 153.5728%343
Chris Davis 2016-09-30 New Buy0.76%$112.81 - $121.04 $ 153.5731%1,504,313
Richard Pzena 2016-09-30 Add 0.09%$112.81 - $121.04 $ 153.5731%155,248
Joel Greenblatt 2016-09-30 Add 60.98%0.02%$112.81 - $121.04 $ 153.5731%25,149
David Dreman 2016-09-30 Reduce -7.01%0.05%$112.81 - $121.04 $ 153.5731%9,163
George Soros 2016-09-30 Sold Out 0.11%$112.81 - $121.04 $ 153.5731%0
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans    NAICS: 524114    SIC: 6324
Compare:NYSE:ANTM, NYSE:CI, NAS:ESRX, NYSE:HUM, NYSE:CVS, NYSE:CNC, NYSE:WCG, NYSE:MOH, NAS:MGLN, NAS:HIIQ, OTCPK:OPRX, OTCPK:HFRN, NAS:CNXR, OTCPK:WCUI, NYSE:UNH » details
Traded in other countries:AETB34.Brazil, HE8.Germany,
Headquarter Location:USA
Aetna Inc is a diversified health care benefits company. The company offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health.

Aetna is one of the largest managed-care organizations in the U.S., with over 22 million medical members. This member count will increase significantly if the firm is able to close the Humana acquisition. The firm provides health insurance services to its members through products that encompass every major insurance market--individual, group, and government sponsored. Aetna has a large nationwide operation and competes in most major U.S. geographies.

Top Ranked Articles about Aetna Inc

David Dreman’s Top 5 Health Care Buys for the 2nd Quarter Guru takes new positions in stocks he previously sold
Dreman Value Management founder David Dreman (Trades, Portfolio) established 210 new positions in the second quarter, of which 20 were in health care companies. His top five health care buys were Aetna Inc. (NYSE:AET), Zimmer Biomet Holdings Inc. (NYSE:ZBH), Amgen Inc. (NASDAQ:AMGN), Biogen Inc. (NASDAQ:BIIB) and Cardinal Health Inc. (NYSE:CAH). Read more...
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aetna Inc. (AET)
Aetna Announces A Brighter Experience For All Dental Members
David Swensen Sells 5 Holdings, Buys 2 Others An overview of the guru's 1st-quarter trades
David Swensen (Trades, Portfolio) is responsible for managing Yale University's endowment assets and investment funds. He manages a portfolio of six stocks worth $495 million. During the first quarter, the guru traded shares in the following stocks: Read more...
Edward Owens Buys Abbott Labs, Sells Allergan, Amgen, Aetna Vanguard Health Care Fund's largest 1st-quarter trades
Edward Owens has managed the Vanguard Health Care Fund (Trades, Portfolio) since its inception in May 1984. It invests primarily in health care companies. Read more...
Insiders Roundup: Facebook, General Electric, Aetna The largest insider trades of the week
The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$200,000+,” the duration to “March 2017” and All Insider Sales to “$5,000,000+.” Read more...
Eaton Vance Worldwide Health Sciences Fund Adds 4 Stocks to Portfolio Health care fund reports fourth-quarter activity
Jason Kritzer, vice president of Eaton Vance Management, invests in companies with a bottom-up, proprietary research approach. The portfolio manager of the Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio) invested in four companies during the first quarter: Aetna Inc. (NYSE:AET), Humana Inc. (NYSE:HUM), Hologic Inc. (NASDAQ:HOLX) and Teleflex Inc. (NYSE:TFX) Read more...
Diamond Hill Sells Morgan Stanley and IBM, Buys Pepsi The guru's largest 4th-quarter trades
Diamond Hill Capital (Trades, Portfolio) is a registered investment adviser based in Columbus, Ohio. During the fourth quarter the guru traded shares in the following stocks: Read more...
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aetna Inc. (AET) & Lead Plaintiff Deadline - March 27, 2017

NEW YORK, March 24, 2017 (GLOBE NEWSWIRE) -- -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Aetna Inc. (“Aetna” or the “Company”) (:AET) and certain of its officers, on behalf of shareholders who purchased Aetna securities between August 15, 2016 and January 20, 2017, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/aet. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The complaint alleges that throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) Aetna and its senior executives tried to influence Aetna’s participation in the Public Exchanges for positive treatment from regulators regarding the Humana acquisition; (2) Aetna threatened to limit its involvement in public health insurance exchanges if the Department of Justice (“DOJ”) tried to block the merger; (3) Aetna did not withdraw from certain public health insurance exchanges for business reasons as Defendants claimed, but to follow through on its threat of leaving the marketplace once the DOJ filed suit and to improve its litigation position; (4) Aetna withdrew from public health insurance exchanges that were profitable for Aetna; and (5) consequently, Defendants’ statements regarding Aetna’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/aet or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Aetna you have until March 27, 2017 to request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]

Read more...
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, March 24, 2017 (GLOBE NEWSWIRE) -- Lundin Law PC, a shareholder rights firm announces a class action lawsuit against Aetna Inc. (“Aetna” or the “Company”) (:AET) concerning possible violations of federal securities laws. Investors who purchased or otherwise acquired shares between August 15, 2016 and January 20, 2017 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the March 27, 2017 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here, or call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at [email protected]. No class has been certified in the above action yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member. The Complaint alleges that during the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: Aetna and its senior executives tried to influence Aetna's participation in the Public Exchanges for positive treatment from regulators regarding the Humana acquisition; that the Company threatened to cut back its participation in public health insurance exchanges if the Department of Justice ("DOJ") tried to block the merger; that Aetna withdraw from some public health insurance exchanges to complete its threat of leaving the marketplace once the DOJ filed suit to better its litigation; that Aetna withdrew from public health insurance exchanges that were profitable for Aetna; and that due to the above, Defendants' statements regarding Aetna's business, operations, and prospects were false and misleading and/or lacked a reasonable basis. When this information was released to the public, the value of Aetna stock fell, causing investors harm. Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders' rights. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
[email protected]

Read more...

Ratios

vs
industry
vs
history
PE Ratio 33.53
AET's PE Ratio is ranked lower than
100% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.18 vs. AET: 33.53 )
Ranked among companies with meaningful PE Ratio only.
AET' s PE Ratio Range Over the Past 10 Years
Min: 5.42  Med: 12.66 Max: 45.35
Current: 33.53
5.42
45.35
Forward PE Ratio 15.29
AET's Forward PE Ratio is ranked higher than
64% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.39 vs. AET: 15.29 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 33.53
AET's PE Ratio without NRI is ranked lower than
100% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.18 vs. AET: 33.53 )
Ranked among companies with meaningful PE Ratio without NRI only.
AET' s PE Ratio without NRI Range Over the Past 10 Years
Min: 5.42  Med: 12.66 Max: 45.35
Current: 33.53
5.42
45.35
Price-to-Owner-Earnings 39.83
AET's Price-to-Owner-Earnings is ranked lower than
88% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.73 vs. AET: 39.83 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
AET' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.35  Med: 12.54 Max: 42.23
Current: 39.83
5.35
42.23
PB Ratio 3.31
AET's PB Ratio is ranked lower than
61% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.78 vs. AET: 3.31 )
Ranked among companies with meaningful PB Ratio only.
AET' s PB Ratio Range Over the Past 10 Years
Min: 0.88  Med: 1.84 Max: 3.51
Current: 3.31
0.88
3.51
PS Ratio 0.86
AET's PS Ratio is ranked lower than
58% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.64 vs. AET: 0.86 )
Ranked among companies with meaningful PS Ratio only.
AET' s PS Ratio Range Over the Past 10 Years
Min: 0.29  Med: 0.54 Max: 1.13
Current: 0.86
0.29
1.13
Price-to-Free-Cash-Flow 28.82
AET's Price-to-Free-Cash-Flow is ranked lower than
76% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.35 vs. AET: 28.82 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
AET' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 4.49  Med: 11.46 Max: 30.56
Current: 28.82
4.49
30.56
Price-to-Operating-Cash-Flow 24.54
AET's Price-to-Operating-Cash-Flow is ranked lower than
70% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.27 vs. AET: 24.54 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
AET' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.68  Med: 9.69 Max: 26.02
Current: 24.54
3.68
26.02
EV-to-EBIT 16.94
AET's EV-to-EBIT is ranked lower than
90% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.25 vs. AET: 16.94 )
Ranked among companies with meaningful EV-to-EBIT only.
AET' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.7  Med: 7.5 Max: 19.1
Current: 16.94
3.7
19.1
EV-to-EBITDA 13.96
AET's EV-to-EBITDA is ranked lower than
71% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.19 vs. AET: 13.96 )
Ranked among companies with meaningful EV-to-EBITDA only.
AET' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.4  Med: 6.5 Max: 15.4
Current: 13.96
3.4
15.4
EV-to-Revenue 0.87
AET's EV-to-Revenue is ranked lower than
52% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.77 vs. AET: 0.87 )
Ranked among companies with meaningful EV-to-Revenue only.
AET' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.3  Med: 0.6 Max: 1.1
Current: 0.87
0.3
1.1
PEG Ratio 3.13
AET's PEG Ratio is ranked lower than
79% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.82 vs. AET: 3.13 )
Ranked among companies with meaningful PEG Ratio only.
AET' s PEG Ratio Range Over the Past 10 Years
Min: 0.27  Med: 0.96 Max: 6.51
Current: 3.13
0.27
6.51
Shiller PE Ratio 29.72
AET's Shiller PE Ratio is ranked lower than
69% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 27.81 vs. AET: 29.72 )
Ranked among companies with meaningful Shiller PE Ratio only.
AET' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.36  Med: 19.42 Max: 47.23
Current: 29.72
10.36
47.23
Current Ratio 0.79
AET's Current Ratio is ranked lower than
71% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.19 vs. AET: 0.79 )
Ranked among companies with meaningful Current Ratio only.
AET' s Current Ratio Range Over the Past 10 Years
Min: 0.54  Med: 0.87 Max: 2.78
Current: 0.79
0.54
2.78
Quick Ratio 0.79
AET's Quick Ratio is ranked lower than
67% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.19 vs. AET: 0.79 )
Ranked among companies with meaningful Quick Ratio only.
AET' s Quick Ratio Range Over the Past 10 Years
Min: 0.54  Med: 0.87 Max: 2.78
Current: 0.79
0.54
2.78
Days Sales Outstanding 35.77
AET's Days Sales Outstanding is ranked lower than
60% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 25.28 vs. AET: 35.77 )
Ranked among companies with meaningful Days Sales Outstanding only.
AET' s Days Sales Outstanding Range Over the Past 10 Years
Min: 16.34  Med: 25.66 Max: 35.77
Current: 35.77
16.34
35.77
Days Payable 49.78
AET's Days Payable is ranked higher than
69% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 44.46 vs. AET: 49.78 )
Ranked among companies with meaningful Days Payable only.
AET' s Days Payable Range Over the Past 10 Years
Min: 38.83  Med: 47.09 Max: 52.51
Current: 49.78
38.83
52.51

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.98
AET's Dividend Yield % is ranked lower than
84% of the 31 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.38 vs. AET: 0.98 )
Ranked among companies with meaningful Dividend Yield % only.
AET' s Dividend Yield % Range Over the Past 10 Years
Min: 0.05  Med: 0.8 Max: 1.77
Current: 0.98
0.05
1.77
Dividend Payout Ratio 0.28
AET's Dividend Payout Ratio is ranked higher than
75% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.25 vs. AET: 0.28 )
Ranked among companies with meaningful Dividend Payout Ratio only.
AET' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.01  Med: 0.12 Max: 0.28
Current: 0.28
0.01
0.28
3-Year Dividend Growth Rate 7.70
AET's 3-Year Dividend Growth Rate is ranked higher than
50% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.70 vs. AET: 7.70 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
AET' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 171.4
Current: 7.7
0
171.4
Forward Dividend Yield % 1.30
AET's Forward Dividend Yield % is ranked lower than
81% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.65 vs. AET: 1.30 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 2.04
AET's 5-Year Yield-on-Cost % is ranked lower than
71% of the 41 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.04 vs. AET: 2.04 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
AET' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.11  Med: 1.68 Max: 3.72
Current: 2.04
0.11
3.72
3-Year Average Share Buyback Ratio 1.00
AET's 3-Year Average Share Buyback Ratio is ranked higher than
56% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.00 vs. AET: 1.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
AET' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -10.2  Med: 0.6 Max: 8.8
Current: 1
-10.2
8.8

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 14.81
AET's Price-to-Tangible-Book is ranked lower than
81% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.27 vs. AET: 14.81 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
AET' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.55  Med: 3.63 Max: 23.42
Current: 14.81
0.55
23.42
Price-to-Intrinsic-Value-Projected-FCF 1.15
AET's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
53% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.04 vs. AET: 1.15 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
AET' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.23  Med: 0.69 Max: 2
Current: 1.15
0.23
2
Price-to-Intrinsic-Value-DCF (Earnings Based) 2.33
AET's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
90% of the 10 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.60 vs. AET: 2.33 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
AET' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.39  Med: 0.91 Max: 2.76
Current: 2.33
0.39
2.76
Price-to-Median-PS-Value 1.59
AET's Price-to-Median-PS-Value is ranked lower than
68% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.23 vs. AET: 1.59 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
AET' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.29  Med: 0.84 Max: 2.35
Current: 1.59
0.29
2.35
Price-to-Peter-Lynch-Fair-Value 4.25
AET's Price-to-Peter-Lynch-Fair-Value is ranked lower than
100% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.63 vs. AET: 4.25 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
AET' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.19  Med: 0.84 Max: 5.14
Current: 4.25
0.19
5.14
Price-to-Graham-Number 4.69
AET's Price-to-Graham-Number is ranked lower than
92% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.77 vs. AET: 4.69 )
Ranked among companies with meaningful Price-to-Graham-Number only.
AET' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.36  Med: 1.53 Max: 5.77
Current: 4.69
0.36
5.77
Earnings Yield (Greenblatt) % 5.90
AET's Earnings Yield (Greenblatt) % is ranked lower than
72% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.85 vs. AET: 5.90 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
AET' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 5.2  Med: 13.4 Max: 27.2
Current: 5.9
5.2
27.2
Forward Rate of Return (Yacktman) % 12.37
AET's Forward Rate of Return (Yacktman) % is ranked lower than
67% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.88 vs. AET: 12.37 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
AET' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 6  Med: 19.7 Max: 54.7
Current: 12.37
6
54.7

More Statistics

Revenue (TTM) (Mil) $62,197.30
EPS (TTM) $ 4.58
Beta0.53
Short Percentage of Float1.09%
52-Week Range $104.59 - 164.52
Shares Outstanding (Mil)332.10

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 60,819 62,892 66,846
EPS ($) 9.30 10.11 11.14
EPS without NRI ($) 9.30 10.11 11.14
EPS Growth Rate
(Future 3Y To 5Y Estimate)
15.02%
Dividends per Share ($) 1.34 1.34 1.50
» More Articles for NYSE:AET

Headlines

Articles On GuruFocus.com
David Dreman’s Top 5 Health Care Buys for the 2nd Quarter Aug 25 2017 
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aetna Inc. (AET) Aug 21 2017 
Aetna Announces A Brighter Experience For All Dental Members Aug 07 2017 
Hedge Funds’ Favorite Health Care Stocks Face Earnings This Week Aug 01 2017 
David Swensen Sells 5 Holdings, Buys 2 Others Jun 06 2017 
Edward Owens Buys Abbott Labs, Sells Allergan, Amgen, Aetna May 23 2017 
Insiders Roundup: Facebook, General Electric, Aetna May 19 2017 
Eaton Vance Worldwide Health Sciences Fund Adds 4 Companies May 17 2017 
Diamond Hill Sells Morgan Stanley and IBM, Buys Pepsi Mar 28 2017 
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aetna I Mar 24 2017 

More From Other Websites
Trump pressures U.S. senators to back Republican healthcare bill Sep 23 2017
Anthem to Boost Medicare in Florida With HealthSun Buyout Sep 22 2017
Is Aetna Inc. (AET) a Great Stock for Value Investors? Sep 22 2017
What it takes to score the ‘best job in America’ Sep 21 2017
5 Things Women Can Do to Become CEO of a Company Sep 21 2017
Versartis, Inc. (VSAR) in Focus: Stock Moves 11.5% Higher Sep 21 2017
See what the IHS Markit Score report has to say about Aetna Inc. Sep 21 2017
Short Sellers Take Aim at Vulnerable Health Carriers Sep 20 2017
Envision Healthcare Makes Organizational Changes, Here's Why Sep 20 2017
Aetna, Inc. breached its 50 day moving average in a Bearish Manner : AET-US : September 20, 2017 Sep 20 2017
As clock ticks, Republicans try to move ahead on Obamacare repeal Sep 19 2017
Healthcare Reform: Who Suffers? Sep 19 2017
Public Exchange Woes Hit Health Insurers: Stocks in Focus Sep 19 2017
New York City agency approves $9.4 million in tax breaks for Aetna Sep 19 2017
5 Reasons Why You Should Buy Aetna's (AET) Stock Right Now Sep 18 2017
Take Two: Inside Bill Cassidy's Plan To Replace Obamacare Sep 17 2017
4 HMO Stocks Standing Out in a Top-Ranked Industry Sep 15 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}